Search for: "State v. Sample"
Results 3841 - 3860
of 4,544
Sorted by Relevance
|
Sort by Date
3 Oct 2013, 4:00 am
Clark Holdings Ltd. v HOOPP Realty Inc. [read post]
2 Mar 2017, 12:44 pm
(Rivera v. [read post]
26 Jun 2014, 4:18 am
EEOC v. [read post]
25 Apr 2019, 7:09 am
The primary constitutional question debated at the Court on Tuesday in Department of Commerce v. [read post]
6 Sep 2011, 10:12 pm
(Other state anti-stalking statutes can be found here.) [read post]
7 Jun 2023, 6:00 am
New York Convention to enforce international arbitration awards, and the dispute resolution provision is critical.A sample dispute resolution provision follows: (d) Conducting Arbitration and Arbitration Rules. [read post]
13 Feb 2023, 9:05 pm
We use a large sample of 27,164 SEC comment letters about executive compensation disclosure from 2005 to 2020. [read post]
5 Dec 2011, 8:30 am
All of that is merely a sampling of what Public Citizen did this year. [read post]
17 Jun 2023, 4:30 pm
(Justice Barrett readily cited California v. [read post]
14 Aug 2019, 10:56 am
In the case of Waste v. [read post]
14 Aug 2019, 10:56 am
In the case of Waste v. [read post]
18 Apr 2022, 4:40 pm
The contaminated sample was collected at the firm on June 25, 2009. [read post]
20 Jun 2010, 8:04 pm
” Buckles v. [read post]
2 May 2022, 10:41 am
The decision in People v. [read post]
23 Nov 2010, 9:32 am
And that just covers the United States. [read post]
20 Jun 2010, 8:04 pm
” Buckles v. [read post]
22 Aug 2023, 5:42 am
Secretary of State before implementing any technical changes. [read post]
3 Sep 2020, 9:05 pm
” Jackson and Rothstein concluded by pointing to sample regulations that were exemplary in their use of cost-benefit analysis, highlighting the consumer protection regulations that emerged after the passage of th [read post]
27 Feb 2014, 12:10 pm
Federal Trade Commission v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
